Skip to content

The Relationship of Speech Function and Quality of Life in Children With Cerebral Palsy: A Longitudinal Study

The Relationship of Speech Function and Quality of Life in Children With Cerebral Palsy: A Longitudinal Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01948154
Enrollment
300
Registered
2013-09-23
Start date
2013-02-28
Completion date
2017-12-31
Last updated
2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Quality of Life, Speech Function

Keywords

Cerebral Palsy, Early Intervention, Speech Function, Quality of Life

Brief summary

Cerebral palsy (CP) encompass a group of non-progressive, non-contagious motor conditions that cause physical disability in human development. It is not infrequently to note concurrent impairment in sensory, intelligence, vision and auditory in those patients. Many studies have documented Cerebral palsy is associated with a variety of neuromotor disorders that frequently affect the speech production system. The speech function impairment varied widely due to different severity of diseases involved. The investigators hypothesize such impairment of speech function may affect degree of social participation and eventually the quality of life (QoL).

Detailed description

Cerebral palsy (CP) encompass a group of non-progressive, non-contagious motor conditions that cause physical disability in human development. It is not infrequently to note concurrent impairment in sensory, intelligence, vision and auditory in those patients. Many studies have documented Cerebral palsy is associated with a variety of neuromotor disorders that frequently affect the speech production system. The speech function impairment varied widely due to different severity of diseases involved. The investigators hypothesize such impairment of speech function may affect degree of social participation and eventually the quality of life (QoL). The investigators study aim in this project include: (1) to find the differences in speech function in normal developed children and in children with CP with different severity; (2) the relationship between speech function and QoL in children with CP; (3) to seek the predictable factor involving motor speech function in children with CP from the framework of International Classification of Functioning, Disability and Health - Children and Youth Version (ICF-CY). This will be a 3-year longitudinal project recruiting 110-130 children in total. The investigators will have children with CP (n=60\ 80) and normal (n=50) from 2-12 years old under consent of their family. The investigator's study will be based on structure of ICF-CY. In the first year, basic clinical assessments including motor, mental, vocabulary, motor speech function, general development, and subjective questionnaires on adaptation, participation, development and quality of life will be collected. During the second to the third year, all measurements will be repeated in the end of 6- and 12-month to follow the performance of children with CP and those with normal development. The anticipated outcomes of this study are: (1) to observe the longitudinal change of speech function and QoL in children with CP. (2) Using ICF-CY items in rehabilitation services to describe the speech function and participation of social life for children with CP. (3)To identify the influencing factors and predictors of motor speech function for children with CP.

Interventions

None listed

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

1\. Subjects (Patients selection): A.50 healthy subjects B.30-40 2-5y11m y/o CP subjects C.30-40 6-12 CP subjects (children with cerebral palsy) Inclusion Criteria: Inclusion Criteria: 1. Parents or guardians who signed informed consent 2. Age 6-12 year old 3. Diagnosed to have cerebral palsy

Exclusion criteria

1. Concurrent medical condition (such as: seizure, infection) 2. Surgery within 3 months 3. Botulinum toxin-A injection within 3 months 4. Concurrent progressive or degenerative diseases, peripheral neuropathy, spinal cord injury.

Design outcomes

Primary

MeasureTime frameDescription
change in General Developmental Assessment (CDIIT) in 6 month and 12 month follow upbaseline, 6 month, 12 monthchange of CDIIT

Secondary

MeasureTime frameDescription
change of Mental Abilitybaseline, 6 month, 12 monthchange of Mental Ability (BSID-II, WPPSI-R, WISC-IV)in 6 month, 12 month follow up

Other

MeasureTime frameDescription
change of Motor Speech in 6 month, 12 monthbaseline, 6 month,12 monthMotor Speech Assessment (VMPAC, PCC)in 6 month, 12 month follow up
Language Assessmentbaseline, 6 month, 12 monthLanguage Assessment (PPVT-R; CLST)in 6 month, 12 month follow up

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026